Clinical Trial

Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 4-6 Years Old

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a study to evaluate the effects of a prebiotic, AHCC, a standardized extract of cultured Lentinula edodes mycelia, on immunologic markers and the incidence of respiratory tract infections in children.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12-31 -> 2027-02-28 2026-07-11
minor Completion pushed: 2026-12-31 -> 2027-02-28 2026-07-11
Trial Details
NCT Number NCT07479394
Lead Sponsor Hasanuddin University
Collaborators: Amino Up Co. Ltd., Sapporo, Japan
Conditions Respiratory Tract Infections (RTI)
Enrollment 60 participants
Start Date 2026-08-15
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-10